SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development
07. September 2017 09:13 ET
|
SPR Therapeutics, LLC
CLEVELAND, Sept. 07, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics, LLC (SPR), a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and...
Opioid Concerns and Work Interference Cited as Top Reasons to Delay Knee Replacement Surgery
03. August 2017 11:03 ET
|
SPR Therapeutics, LLC
CLEVELAND, Ohio, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Patients in need of a total knee replacement (TKR) often delay surgery by two or more years because of concerns about the duration of postoperative...
SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy
15. Mai 2017 09:03 ET
|
SPR Therapeutics, LLC
CLEVELAND, May 15, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics (SPR) has been awarded a $6M four-year contract from the U.S. Department of Defense (DoD) to further advance its SPRINT™ Peripheral Nerve...
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
21. März 2017 09:33 ET
|
SPR Therapeutics, LLC
CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...
Les C. Vinney Named 2016 NACD Top 100 Directors
19. Januar 2017 09:30 ET
|
SPR Therapeutics, LLC
CLEVELAND, Jan. 19, 2017 (GLOBE NEWSWIRE) -- The National Association of Corporate Directors (NACD) has named SPR® Therapeutics’ Board Member, Les C. Vinney, one of the top 100 most influential...
SPR Therapeutics Names Dave Youngberg Vice President of Sales
17. Januar 2017 09:30 ET
|
SPR Therapeutics, LLC
CLEVELAND, Jan. 17, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics announced today that industry veteran, Dave Youngberg, has joined the neurostimulation company as Vice President of Sales. ...